CLARIVATE PLC
NYSE:CLVT
CLARIVATE PLC
Founded with a vision to transform the vast world of information into a wellspring of actionable insights, Clarivate PLC has curated an impressive journey in the realm of data and analytics. The company emerged as a pivotal player by offering a suite of products and services designed to assist organizations in harnessing the power of data. Specializing in innovation lifecycle management, Clarivate provides crucial insights that fuel research and development across industries, empowering clients to make informed decisions. The firm's expansive portfolio, encompassing brands like Web of Science, Cortellis, and Derwent, stands as a testament to its commitment to delivering high-quality, data-driven solutions.
Clarivate thrives financially by licensing its data-driven platforms and analytics tools, enabling clients to navigate challenges in a data-intensive world. The company's subscription-based model ensures a continuous revenue stream, complimented by its ability to tailor solutions to meet the evolving demands of its diverse clientele. By facilitating access to critical scientific and academic content, providing insights into intellectual property, and enhancing competitive analysis frameworks, Clarivate positions itself not merely as a data provider but as an indispensable partner in the strategic growth of businesses worldwide. The firm's ongoing pursuit of innovation ensures that it remains ahead in a rapidly evolving market, maintaining its role as a key enabler of knowledge-driven success.
Founded with a vision to transform the vast world of information into a wellspring of actionable insights, Clarivate PLC has curated an impressive journey in the realm of data and analytics. The company emerged as a pivotal player by offering a suite of products and services designed to assist organizations in harnessing the power of data. Specializing in innovation lifecycle management, Clarivate provides crucial insights that fuel research and development across industries, empowering clients to make informed decisions. The firm's expansive portfolio, encompassing brands like Web of Science, Cortellis, and Derwent, stands as a testament to its commitment to delivering high-quality, data-driven solutions.
Clarivate thrives financially by licensing its data-driven platforms and analytics tools, enabling clients to navigate challenges in a data-intensive world. The company's subscription-based model ensures a continuous revenue stream, complimented by its ability to tailor solutions to meet the evolving demands of its diverse clientele. By facilitating access to critical scientific and academic content, providing insights into intellectual property, and enhancing competitive analysis frameworks, Clarivate positions itself not merely as a data provider but as an indispensable partner in the strategic growth of businesses worldwide. The firm's ongoing pursuit of innovation ensures that it remains ahead in a rapidly evolving market, maintaining its role as a key enabler of knowledge-driven success.
Guidance Met: Clarivate delivered on its full-year financial guidance for the first time since 2019, hitting the high end of its initial targets for 2025.
Strategic Divestiture: The company is actively pursuing the sale of its Life Sciences & Health segment to sharpen focus on Academia & Government (A&G) and Intellectual Property (IP) businesses and reduce leverage.
Strong Proprietary Revenue: 97% of revenue comes from proprietary solutions, with a stable customer retention rate of 93%, which management views as a strong moat against AI-driven disruption.
AI-Driven Growth: Management sees AI as an amplifier, not a threat, launching multiple AI-powered solutions and embedding them in workflows across all segments.
Free Cash Flow: 2025 free cash flow reached $365 million, expected to rise about 10% to $400 million in 2026.
Improved Recurring Revenue: Recurring revenue mix increased to 88%, with recurring organic revenue targeted to grow 1–2% in 2026.
Operational Momentum: Organic ACV grew nearly 2% in 2025; further acceleration to 2–3% is guided for 2026.
Capital Allocation: Management is prioritizing deleveraging over buybacks in 2026 despite share repurchases in 2025, due to the market environment.
